PRM vs. LLAI, ABDX, GENI, GDR, VRCI, BVX, FDBK, KNB, MXC, and CNSL
Should you be buying Proteome Sciences stock or one of its competitors? The main competitors of Proteome Sciences include LungLife AI (LLAI), Abingdon Health (ABDX), GENinCode (GENI), genedrive (GDR), Verici Dx (VRCI), BiVictriX Therapeutics (BVX), Feedback (FDBK), Kanabo Group (KNB), Argent BioPharma (MXC), and Cambridge Nutritional Sciences (CNSL). These companies are all part of the "medical" sector.
LungLife AI (LON:LLAI) and Proteome Sciences (LON:PRM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.
LungLife AI has a net margin of 0.00% compared to LungLife AI's net margin of -48.59%. LungLife AI's return on equity of 0.00% beat Proteome Sciences' return on equity.
LungLife AI has a beta of -0.19, suggesting that its share price is 119% less volatile than the S&P 500. Comparatively, Proteome Sciences has a beta of -0.02, suggesting that its share price is 102% less volatile than the S&P 500.
42.2% of LungLife AI shares are held by institutional investors. Comparatively, 23.0% of Proteome Sciences shares are held by institutional investors. 48.7% of LungLife AI shares are held by insiders. Comparatively, 19.5% of Proteome Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Proteome Sciences has higher revenue and earnings than LungLife AI. Proteome Sciences is trading at a lower price-to-earnings ratio than LungLife AI, indicating that it is currently the more affordable of the two stocks.
Proteome Sciences received 162 more outperform votes than LungLife AI when rated by MarketBeat users.
In the previous week, Proteome Sciences had 2 more articles in the media than LungLife AI. MarketBeat recorded 2 mentions for Proteome Sciences and 0 mentions for LungLife AI. Proteome Sciences' average media sentiment score of 0.00 equaled LungLife AI'saverage media sentiment score.
Summary
Proteome Sciences beats LungLife AI on 8 of the 13 factors compared between the two stocks.
Get Proteome Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Proteome Sciences Competitors List
Related Companies and Tools
